Home
NICE Guidance
Conditions and diseases
Cancer
Breast cancer
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
Technology appraisal guidance [TA263]
Published:
22 August 2012
Guidance
Tools and resources
Information for the public
History
Do no do examples
Do no do examples for Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
Title
Year published
Impact Level
No results could be found